Sofosbuvir, a new drug, is offering impressive cure rates for Hepatitis C patients with two subtypes of the disease - genotypes 2 and 3, according to researchers led by Weill Cornell Medical College. Approximately 1 in every 4 hepatitis C patients in the USA has one of these two subtypes...